Mass production system for recombinant bagworm silk protein
By modifying the recombinant bagworm fibroin H chain protein to delete terminal regions, the production of high-purity bagworm silk is enhanced, addressing the challenges of quantity and purity in genetic recombination methods, facilitating efficient mass production.
Patent Information
- Application Number
- JP2021520887
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-05-23
- Filing Date
- 2020-05-25
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2040-05-25
AI Technical Summary
The challenge of mass-producing high-purity bagworm silk for textile applications is hindered by the difficulty in obtaining large quantities of bagworm nests and the inefficiency of removing contaminants, while genetic recombination methods face issues with sequencing the full-length gene sequence of the fibroin H chain protein, which is crucial for producing recombinant bagworm silk.
A modified recombinant bagworm fibroin H chain protein (m-rbFib H) is developed by deleting either the N-terminal or C-terminal regions of the rbFib H protein, enhancing expression levels when introduced into microbial hosts like E. coli, using a modified gene expression vector that includes specific amino acid sequences and structures.
The m-rbFib H protein can be produced in large quantities, overcoming expression suppression and degradation issues, enabling efficient mass production of recombinant bagworm silk with improved properties.
Smart Images

Figure 0007581195000002 
Figure 0007581195000003 
Figure 0007581195000001
Abstract
Description
[Technical field]
[0001] The present invention relates to a gene expression enhancement system that increases the production of fibroin H chain protein, the main fiber component of bagworm silk, produced using genetic engineering technology, and a method for producing recombinant bagworm fibroin H chain protein using the system. [Background technology]
[0002] The threads that make up insect cocoons and the hair of mammals have been used since ancient times as animal fibers for clothing, etc. In particular, silk threads derived from silkworms, the larvae of the silkworm moth (Bombyx mori) (often referred to as "silkworm silk threads" in this specification) are highly valued as a high-quality natural material even today because of their excellent moisture absorption / release, moisture retention, and heat retention properties, as well as their unique luster and smooth texture.
[0003] However, in nature, there are animal fibers that have properties comparable to or even superior to those of silkworm silk. For example, the silk spun by bagworms (often referred to as "bagworm silk" in this specification) is one such example. Bagworms are a general term for the larvae of moths belonging to the family Psychidae in the order Lepidoptera. They are known to live in a bag nest, which is usually a spindle- or cylindrical nest made of pieces of leaves or branches entangled with silk, and to live with the nest for the entire larval stage, even moving the nest when feeding.
[0004] This bagworm silk has mechanical properties superior to silkworm silk. For example, in terms of elastic modulus, bagworm silk from the brown bagworm moth (Eumeta minuscula) is 3.5 times stronger than silkworm silk, boasting extremely high strength (Non-Patent Documents 1 and 2). In addition, the cross-sectional area of a single filament of bagworm silk is only about 1 / 7 that of a single filament of silkworm silk, making it possible to produce thin, lightweight fabrics with a fine grain and a smooth feel. Moreover, bagworm silk has a luster and lustre equal to or greater than that of silkworm silk. Therefore, bagworm silk could be an extremely promising animal fiber as a new natural material.
[0005] However, there are several issues that need to be resolved before bagworm silk can be put to practical use. One of these is mass production. To put bagworm silk to practical use as a fiber material, it is essential to obtain a large amount of bagworm nests. However, the amount of bagworm nests collected in the wild is not enough for mass production, so it is necessary to mass-raise bagworms and find a method to efficiently harvest silk from them.
[0006] Another major problem in putting bagworm silk to practical use is its purity. Impurities such as pieces of leaves and branches always adhere to the surface of bagworm nests. To make it practical as a fiber material from a quality standpoint, these impurities must be completely removed. However, the removal process requires an enormous amount of effort and cost, and it is difficult to completely remove the impurities from bagworm nests using existing technology. As a result, until now it was only possible to obtain low-quality bagworm silk that was dyed with pigments derived from the impurities, which was expensive to do.
[0007] As a solution to the above problems, methods have been developed to efficiently harvest high-purity bagworm silk from bagworms, as disclosed in Patent Documents 1 and 2. However, the bagworm silk industry is still in its infancy. The facilities and systems required for mass-production of bagworm silk are still under development, and it will take some time before mass production can begin.
[0008] As a solution to the above problem, in addition to the method of extracting silk directly from bagworms, there is a method of mass-producing recombinant bagworm silk using genetic engineering technology. By introducing the cloned bagworm silk gene into a host and expressing it, it is possible to mass-produce recombinant bagworm silk within the host cells. However, this production method also has an essential problem in that the full-length gene sequence of bagworm silk, which is the key, has yet to be determined. This is because the fibroin H-chain protein (Fib H protein), the main fiber component of silk, has an amino acid sequence in which many glycine and alanine residues are repeated, making it extremely difficult to determine the base sequence of the full-length fibroin H-chain gene (Fib H gene) using conventional cloning technology. To solve this problem, Patent Document 3 creates a recombinant chimeric Fib H gene consisting of a bagworm Fib H (often referred to herein as "bFib H") gene and a silkworm Fib H (often referred to herein as "sFib H") gene. This chimeric Fib H gene is a full-length artificial gene that is made by fusing a portion of the bFib H gene information of Eumeta japonica, identified by transcriptome analysis, with a portion of the existing sFib H gene information. Patent Document 3 discloses a method for producing chimeric silk thread in which the physical properties of bagworm silk thread are imparted to silkworm silk thread by introducing the chimeric Fib H gene into silkworms to produce genetically modified silkworms and allowing the silkworms to spin silk. [Prior art documents] [Patent documents]
[0009] [Patent Document 1] Patent Publication 2018-197415 [Patent Document 2] Patent Publication No. 2019-013207 [Patent Document 3] Patent Publication No. 2018-074403 [Non-patent literature]
[0010] [Non-Patent Document 1] Shigeyoshi Osaki, 2002, Sen-i-Gakkaishi Journal (Fibers and Industry), 58: 74-78 [Non-Patent Document 2] Gosline JM et al., 1999, 202, 3295-3303 Summary of the Invention [Problem to be solved by the invention]
[0011] In addition to silkworms used in JP 2018-074403 (Patent Document 3), microorganisms such as Escherichia coli and yeast are commonly used as hosts for mass production of proteins. Therefore, in order to construct a bagworm Fib H gene expression system using a microorganism as a mass production host, the present inventors newly cloned the bagworm Fib H gene of the giant bagworm moth and succeeded in obtaining a bagworm Fib H cDNA containing a previously unidentified region. When the obtained recombinant bagworm Fib H (often referred to as "rbFib H" in this specification) gene was incorporated into a gene expression vector for microorganisms and introduced into E. coli to produce rbFib H protein, it was found that the expression level was significantly reduced. Although the specific cause is unknown, it is thought that some control action that suppresses expression was at work. However, in a mass production system of proteins, such a decrease in expression level can be a fatal problem.
[0012] Therefore, an objective of the present invention is to develop an rbFib H gene that enables mass production of rbFib H protein even in a microbial expression system, and an expression vector containing the gene. [Means for solving the problem]
[0013] In order to solve the above problems, the present inventors have conducted extensive research and have found that the expression level of a gene encoding a one-terminal deleted rbFib H protein in which either the N-terminal region or the C-terminal region of rbFib H protein is deleted is significantly increased when the gene is expressed. On the other hand, in the case of a both-terminal deleted rbFib H protein in which only the central region that contributes to the physical properties of Fib H protein remains, an increase in the expression level was observed, but at the same time, the amount of degradation of rbFib H protein was also increased. The present invention is based on these findings and provides the following. (1) A modified rbFib H (m-rbFib H) protein obtained by modifying an rbFib H protein, which includes an N-terminal region, a central region, and a C-terminal region in this order from the N-terminus, wherein the m-rbFib H protein is The protein lacks all or a part of the N-terminal region or all or a part of the C-terminal region of an H protein, and the N-terminal region consists of the amino acid sequence shown in SEQ ID NO:1, an amino acid sequence in which one or more amino acids have been added, deleted or substituted in the amino acid sequence shown in SEQ ID NO:1, or an amino acid sequence having 90% or more amino acid identity with the amino acid sequence shown in SEQ ID NO:1, and the central region consists of three or more central repeat units consisting of identical and / or different amino acid sequences linked together, and the C-terminal region consists of the amino acid sequence shown in SEQ ID NO:2, an amino acid sequence in which one or more amino acids have been added, deleted or substituted in the amino acid sequence shown in SEQ ID NO:2, or an amino acid sequence having 90% or more amino acid identity with the amino acid sequence shown in SEQ ID NO:2, and wherein the central repeat unit contains 30 or more two-amino acid units consisting of glycine and alanine, and an Ala cluster containing 15 to 25 alanines on the N-terminal side, and is composed of 120 to 170 amino acids in total. (2) The m-rbFib H protein according to (1), wherein the Ala cluster consists of the amino acid sequence shown in SEQ ID NO: 3 or 4. (3) The m-rbFib H protein according to (2), wherein the central repeat unit is selected from the amino acid sequences shown in SEQ ID NOs: 5 to 13. (4) An m-rbFib H gene encoding the m-rbFib H protein according to any one of (1) to (3). (5) The m-rbFib H gene according to (4), which consists of any one of the base sequences shown in SEQ ID NO: 16, 18, 24, or 26. (6) An m-rbFib H gene expression vector comprising the m-rbFib H gene according to (4) or (5) in a state capable of being expressed in a host cell. (7) A transformant or its progeny comprising a host comprising the m-rbFib H gene expression vector according to (6). (8) The transformant or its progeny according to (7), wherein the host is a microorganism or a cultured insect cell. (9) A method for producing m-rbFib H protein, comprising: a culture step of culturing the transformant according to (7) or (8) or its progeny under predetermined conditions; and a preparation step of preparing m-rbFib H protein from the culture medium and / or the transformant after the culture step. This specification includes the disclosures of Japanese Patent Application No. 2019-097154, which is the priority basis of this application. Effect of the Invention
[0014] According to the m-rbFib H gene expression vector of the present invention, it is possible to mass-produce m-rbFib H protein by introducing the expression vector into a host and inducing expression. [Brief description of the drawings]
[0015] [Figure 1]The schematic diagram of the structure of the rbFib H protein encoded by the rbFib H gene cloned in the present invention and the m-rbFib H protein encoded by the m-rbFib H gene modified from the rbFib H gene is shown. In this figure, the bw753 protein and the bw592 protein constructed in the Examples are shown as the rbFib H proteins, and the bw592ΔC protein, the bw592ΔN protein, and the bw592ΔN / C protein constructed in the Examples are shown as the m-rbFib H proteins. The black bars in the figure indicate the rbFib H gene amplified fragments used in cloning the rbFib H gene, and indicate the positions on the m-rbFib H protein that correspond to the amino acid regions encoded by the fragments. [Diagram 2] This is a Western blotting diagram of rbFib H protein in each transformant of Example 4. Lane 1 shows bw592, which is an rbFib H protein, lane 2 shows bw592ΔC, which is an m-rbFib H protein, lane 3 shows bw592ΔN, which is an m-rbFib H protein, and lane 4 shows bw592ΔN / C, which is an m-rbFib H protein. The arrows in the diagram indicate the position of the target protein. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] 1. Modified recombinant bagworm fibroin H chain protein 1-1. Overview A first aspect of the present invention is a modified-recombinant bagworm fibroin H chain (herein often referred to as "m-rbFib H") protein. The m-rbFib H protein is a protein encoded by a modified-recombinant bagworm fibroin H chain gene (m-rbFib H gene) which is an rbFib H gene newly cloned by the present inventors and further modified.
[0017] According to the m-rbFib H gene of the present invention, by expressing an expression vector containing the gene in a host cell such as a microorganism, it is possible to express 15 times more recombinant protein than the rbFib H gene, thereby enabling mass production of rbFib H protein using a microbial gene expression system.
[0018] 1-2.Definition of Terms The following terms frequently used herein are defined as follows:
[0019] As mentioned above, "bagbug" is a general term for the larvae of moths belonging to the family Psychidae in the order Lepidoptera. Therefore, although it originally refers to the larvae of various moths in the family Psychidae, when simply written as bagbug in this specification, it basically means the giant bagbug used in the construction of the cDNA library for cloning the rbFib H gene.
[0020] In this specification, "silk thread" refers to thread derived from insects or arachnid organisms, and is a protein thread spun by their larvae or adults for the purposes of nesting, moving, anchoring, spinning cocoons, capturing food, etc. In this specification, when simply written as "silk thread," it generally means a broad and general silk thread without specifying the name of the organism of origin. When referring to silk thread derived from a specific organism, the name of the organism of origin is placed before the word "silk thread," such as silkworm silk thread or bagworm silk thread.
[0021] "Fibroin H chain (Fib H) protein" is one of the proteins that constitute fibroin, which is the main fiber component of silk thread. For example, silkworm fibroin is mainly composed of three proteins, namely, Fib H protein, Fib L protein, and p25 protein. Among these, Fib H protein is the main component protein of fibroin, and the properties of silk thread are mainly provided by Fib H protein. Therefore, in this specification, Fib H protein, which is a fiber component that constitutes silk thread, may also be referred to as silk thread. In this specification, when "Fib H" is used, the name of the organism from which it originates is not specified in principle. When expressing a Fib H protein derived from a specific organism, the name of the organism from which it originates or its initials are added before Fib H, such as silkworm Fib H protein (sFib H protein) and bagworm Fib H protein (bFib H protein).
[0022] In this specification, the term "recombinant fibroin H chain protein" (rFib H protein) refers to a Fib H protein encoded by a recombinant fibroin H chain gene cloned using a gene cloning technique. The rFib H protein does not need to be composed of the same amino acid sequence as the wild-type full-length Fib H protein, as long as it contains the basic components of the Fib H protein. The basic components of the Fib H protein include the N-terminal region, the central region, and the C-terminal region. These basic components will be described in detail in the chapter "1-3. Composition". In addition, the rFib H protein does not need to be a Fib H protein derived from a single organism, and may be a chimeric Fib H protein composed of polypeptides derived from two or more organisms. For example, a chimeric Fib H protein composed of Fib H proteins of a bagworm and a silkworm can be mentioned. In this specification, when more than half of the amino acids in the entire amino acid sequence constituting the rFib H protein are derived from a specific insect, the initial of the name of the specific insect is added after the "r" in the rFib H protein. For example, when 90% or more of the amino acid sequence constituting an rFib H protein is derived from the amino acid sequence of the bagworm Fib H protein, it is designated as "rbFib H protein."
[0023] As used herein, the term "modified recombinant fibroin H chain protein" (m-rFib H protein) refers to a protein that is based on the rFib H protein and is partially artificially modified to have an amino acid sequence different from that of the wild-type Fib H protein. Examples of m-rFib H protein include mutant rFib H proteins in which one or more amino acids have been added, deleted, and / or substituted in the amino acid sequence of rFib H protein. Specifically, examples of such rFib H proteins include rFib H proteins in which the N-terminal region and / or C-terminal region, which are basic components of Fib H protein, have been deleted.
[0024] As used herein, "fibroin H chain gene" (Fib H gene) refers to a gene encoding the Fib H protein. As with Fib H protein, when the term "Fib H gene" is used herein, the origin of the organism is not important. When expressing a Fib H gene derived from a specific organism, the name of the organism or its initials is placed before Fib H. For example, the Fib H gene derived from a bagworm is expressed as bagworm Fib H gene or bFib H gene.
[0025] As used herein, the term "recombinant fibroin H chain gene" (rFib H gene) refers to a Fib H gene cloned using gene cloning techniques, which encodes the aforementioned recombinant Fib H protein.
[0026] As used herein, the term "modified recombinant fibroin H chain gene" (m-rFib H gene) refers to a gene encoding the aforementioned m-rFib H protein. Similarly, as used herein, the term "modified recombinant bagworm fibroin H chain gene" (m-rbFib H gene) refers to a gene encoding the "m-rbFib H protein."
[0027] As used herein, "recombinant bagworm silk" refers to bagworm silk that contains rbFib H protein (including m-rbFib H protein).
[0028] As used herein, the term "expression vector" refers to an expression system that contains a gene in an expressible state and is capable of controlling the expression.
[0029] As used herein, the term "expressible state" means that a gene contained in the vector is incorporated into an expression vector so as to be expressible in a host cell. Specifically, the gene contained therein is placed under the control of a promoter in the expression vector.
[0030] 1-3.Configuration 1-3-1. Composition of recombinant bagworm fibroin H chain (rbFib H) protein In the present specification, the rbFib H protein includes, as basic components, an N-terminal region, a central region, and a C-terminal region, in that order from the N-terminal side. It may further include a signal sequence or a label peptide. The above-mentioned regions may be directly linked to each other, or may be indirectly linked via any linker sequence. Each region will be specifically described below.
[0031] (N-terminal region) The "N-terminal region" refers to an amino acid region located on the N-terminal side of the central region described below in the amino acid sequence constituting the rbFib H protein, as shown in FIG. 1. Specifically, the amino acid sequence shown in SEQ ID NO: 1, the amino acid sequence shown in SEQ ID NO: 1 in which one or more amino acids have been added, deleted, or substituted, or the amino acid sequence having 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more amino acid identity with the amino acid sequence shown in SEQ ID NO: 1. In the present specification, the amino acid substitution is preferably a conservative amino acid substitution. This is because a conservative amino acid substitution can have substantially the same structure or properties as a wild-type protein. A conservative amino acid refers to the relationship between amino acids classified into the same amino acid group. The amino acid groups include nonpolar amino acids (glycine, alanine, phenylalanine, valine, leucine, isoleucine, methionine, proline, tryptophan), polar amino acids (amino acids other than nonpolar amino acids), charged amino acids (acidic amino acids (aspartic acid, glutamic acid) and basic amino acids (arginine, histidine, lysine), uncharged amino acids (amino acids other than charged amino acids), aromatic amino acids (phenylalanine, tryptophan, tyrosine), branched chain amino acids (leucine, isoleucine, valine), ), as well as aliphatic amino acids (glycine, alanine, leucine, isoleucine, valine), etc. are known. In this specification, "plurality" refers to, for example, 2 to 20, 2 to 15, 2 to 10, 2 to 7, 2 to 5, 2 to 4, or 2 to 3. "Amino acid identity" refers to the ratio (%) of identical amino acid residues to the number of amino acid residues in SEQ ID NO: 1 when two amino acid sequences are aligned and, while introducing gaps into either amino acid sequence as necessary, the degree of amino acid identity between the two sequences is maximized.Amino acid identity can be calculated using the BLAST or FASTA protein search system (Karlin, S. et al., 1993, Proc. Natl. Acad. Sci. USA, 90: 5873-5877; Altschul, S. F. et al., 1990, J. Mol. Biol., 215: 403-410; Pearson, W. R. et al., 1988, Proc. Natl. Acad. Sci. USA, 85: 2444-2448).
[0032] Although Fib H protein usually contains a signal sequence on the N-terminus side, the N-terminal region does not contain a signal sequence.
[0033] (center area) The "central region" is a region that exhibits the physical properties of bFib H protein, and is composed of multiple central repeat units consisting of the same and / or different amino acid sequences linked together. The number of central repeat units is not limited as long as it is 3 or more. There is no particular upper limit, and the central repeat unit may contain, for example, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450, 500 or more central repeat units.
[0034] The "central repeat unit" (often referred to herein as "CRU") consists of a total of 120 to 170 amino acids, and contains one alanine cluster and multiple glycine / alanine units.
[0035] An "alanine cluster" (often referred to as "Ala cluster" in this specification) is a subunit consisting of consecutive alanines (Ala), and is contained on the N-terminal side of a CRU. One Ala cluster contains 15 to 25 alanines, and in addition to alanines, it also contains one glutamic acid or glutamine in the center of the Ala cluster (for example, at the 10th position from the N-terminal side of the Ala cluster). Specific examples of Ala clusters in bFib H protein include, but are not limited to, the amino acid sequences shown in SEQ ID NO: 3 or 4.
[0036] "Glycine / alanine unit (G / A unit)" is a unit consisting of two amino acids, glycine (Gly:G) and alanine (Ala:A), and consists of glycine-alanine (AG) or alanine-glycine (GA). Most CRUs are composed of G / A units, and each unit contains 30 or more, 35 or more, or 40 or more, or 60 or less, 55 or less, or 50 or less G / A units.
[0037] Furthermore, the CRU may contain a non-G / A portion consisting of an amino acid sequence other than glycine and alanine, which consists of 5 to 7 amino acids. The amino acid sequence of the non-G / A portion is not limited. For example, the non-G / A portion consisting of the amino acid sequence shown in SEQ ID NO: 44 or 45 consisting of serine, valine, and tyrosine, or the amino acid sequence shown in SEQ ID NO: 46 is preferable.
[0038] The amino acid sequence constituting the CRU of bFib H protein is not particularly limited as long as it satisfies the conditions of each of the above-mentioned components. Specific examples include, but are not limited to, the amino acid sequences shown in SEQ ID NOs: 5 to 13.
[0039] The CRUs constituting the central region of the bFib H protein are linked to each other directly or via any other linker sequence consisting of 1 to 30 amino acids, 1 to 20 amino acids, or 1 to 10 amino acids.
[0040] As described above, the central region is a region that exhibits the physical properties of bFib H protein. The central region of rbFib H protein has the same or similar physical properties as the central region in wild-type bFib H protein. Here, the central region of the m-rbFib H protein of the present invention only varies in number, and the amino acid sequence is the same as that of the central region of rbFib H protein. Therefore, m-rbFib H protein has, in principle, the same or similar physical properties as rbFib H protein.
[0041] (C-terminal region) The "C-terminal region" refers to an amino acid region located on the C-terminal side of the central region described below in the amino acid sequence constituting rbFib H protein, as shown in Figure 1. Specifically, this refers to the amino acid sequence shown in SEQ ID NO: 2, the amino acid sequence shown in SEQ ID NO: 2 in which one or more amino acids have been added, deleted or substituted, or an amino acid sequence having 90% or more amino acid identity with the amino acid sequence shown in SEQ ID NO: 2.
[0042] (signal peptide) The rbFib H protein of the present invention can optionally contain a signal peptide N-terminal to the N-terminal region.
[0043] A "signal peptide" (signal sequence) is an extracellular transport signal required for the extracellular secretion of a protein biosynthesized by gene expression. After translation, the signal peptide is cleaved and removed by signal peptidase before being secreted outside the cell. A signal peptide has a positively charged amino acid such as lysine or arginine at the N-terminus, followed by a highly hydrophobic amino acid sequence such as alanine, leucine, valine, isoleucine, and phenylalanine.
[0044] Fib H protein usually has an endogenous signal peptide at its N-terminus. bFib H protein also has an endogenous signal peptide at its N-terminus. Therefore, when the rbFib H protein of the present invention of this embodiment contains a signal peptide, it may be either an endogenous signal peptide or an exogenous signal peptide. When the synthesized rbFib H protein is efficiently transferred outside the cell, the signal peptide is preferably, but not limited to, one derived from a host cell expressing a protein to be transferred outside the cell. For example, if the m-rbFib H gene expression vector described in the third embodiment is introduced into a host cell, it is preferable that the m-rbFib H gene contained in the gene expression vector encodes a signal peptide derived from the host. More specifically, if the host is Escherichia coli, the m-rbFib H gene may contain a gene sequence encoding a signal peptide derived from Escherichia coli. The amino acid sequence of the signal peptide or the base sequence encoding it may be any known one and is not limited to any one. For example, an example of an Escherichia coli signal peptide is the amino acid sequence shown in SEQ ID NO: 47. Furthermore, examples of the base sequence encoding the signal peptide of E. coli include the base sequence encoding the amino acid sequence shown in SEQ ID NO:47, specifically the base sequence shown in SEQ ID NO:48.
[0045] The C-terminal side of the signal peptide may have an amino acid sequence including a signal sequence post-insertion sequence that promotes cleavage and secretion of the signal peptide and / or a signal peptidase recognition site that cleaves the signal peptide from the fusion protein. The amino acid sequence of the signal peptide is not particularly limited. Generally, it may be within the range of 3 to 60 amino acids.
[0046] (Labeled peptide) The rbFib H protein of the present invention may contain a label peptide, if necessary. The term "label peptide" refers to a peptide that is expressed together with a polypeptide of interest (here, rbFib H protein) and serves as an indicator for detecting or extracting the polypeptide of interest without inhibiting or suppressing its activity. Usually, the label peptide is configured to be expressed together with the rbFib H protein in the form of a fusion polypeptide. The position at which the label peptide is placed is not limited, but it is generally placed on the N-terminus and / or C-terminus of the rbFib H protein. Examples of label peptides include, but are not limited to, histidine (His) tags (e.g., (His)6-(His) 10 ), peptide tags such as FLAG tags, myc tags, and HA tags, and GFP proteins.
[0047] Specific examples of the amino acid sequence of rbFib H protein include the amino acid sequence shown in SEQ ID NO: 15 constituting the bw592 protein constructed in the Examples described below, and the amino acid sequence shown in SEQ ID NO: 23 constituting the bw753 protein. As shown in Figure 1, the bw592 protein and the bw753 protein contain an E. coli signal peptide consisting of the amino acid sequence shown in SEQ ID NO: 47 at the N-terminus and a His tag at the C-terminus.
[0048] 1-3-2. Construction of modified recombinant bagworm fibroin H chain (m-rbFib H) protein The m-rbFib H protein of this embodiment has a configuration in which all or a part of the N-terminal region and / or all or a part of the C-terminal region of the recombinant bagworm fibroin H chain protein is deleted. The term "part" as used herein refers to one amino acid, or two or more consecutive or non-consecutive amino acids, but less than all, in the amino acid sequence constituting the N-terminal region or the C-terminal region. Preferably, the number of amino acids that can lose the function of the N-terminal region or the C-terminal region corresponds to the part. For example, it is 5, 8, 10, 12, 15, 18, 20 or more consecutive or non-consecutive amino acids.
[0049] However, m-rbFib H protein that exerts the effect of the present invention is only a protein having a configuration in which all or part of the N-terminal region or all or part of the C-terminal region is deleted, and a protein having a configuration in which all or part of the N-terminal region and all or part of the C-terminal region are deleted is included in m-rbFib H protein, but does not exert the effect, and therefore does not correspond to the m-rbFib H protein of interest of the present invention. Therefore, unless otherwise specified, when m-rbFib H protein is written in this specification, it means an rbFib H protein in which all or part of the N-terminal region or all or part of the C-terminal region is deleted.
[0050] In addition to the deletion of the N-terminal region or C-terminal region, the m-rbFib H protein may contain one or more other amino acid addition, deletion, and / or substitution mutations without losing the function of the central region. Even if the whole or part of the N-terminal region is deleted, the m-rbFib H protein may have the signal sequence on the N-terminus.
[0051] As an example of a specific amino acid sequence of the m-rbFib H protein, there is SEQ ID NO: 17 Examples of m-rbFib H proteins include the amino acid sequence shown in SEQ ID NO: 19 constituting the bw592ΔC protein, the amino acid sequence shown in SEQ ID NO: 25 constituting the bw753ΔN protein, and the amino acid sequence shown in SEQ ID NO: 27 constituting the bw753ΔC protein. As described above, the amino acid sequence shown in SEQ ID NO: 21 constituting the bw592ΔN / C protein and the amino acid sequence shown in SEQ ID NO: 29 constituting the bw753ΔN / C protein are m-rbFib H proteins, but do not exhibit the effects of the present invention and therefore do not correspond to the m-rbFib H protein of the present invention.
[0052] 2. Modified recombinant bagworm fibroin H chain gene (m-rbFib H gene) 2-1. Overview A second aspect of the present invention is an m-rbFib H gene. The m-rbFib H gene of this aspect is a gene encoding the m-rbFib H protein described in the first aspect. By expressing the m-rbFib H gene of the present invention in a host cell such as E. coli, it is possible to express a recombinant protein at a level 15-fold or more compared to the unmodified rbFib H gene.
[0053] 2-2.Configuration 2-2-1. Construction of the recombinant bagworm fibroin H chain (rbFib H) gene The rbFib H gene in this specification is a newly cloned rbFib H gene from a cDNA library prepared by the present inventors from the silk gland of the final instar larvae of P. moniliforme. A partial sequence of the rbFib H gene is disclosed in JP 2018-074403 A, but the present inventors have now succeeded in cloning a new rbFib H gene including the N-terminal region and the C-terminal region that were unidentified in JP 2018-074403 A. The rbFib H gene in this specification is a recombinant gene reconstructed to include a base sequence encoding the N-terminal region, the central region, and the C-terminal region, which are basic components, based on the partial base sequence information of the rbFib H gene obtained by the cloning.
[0054] When the m-rbFib H protein is expressed as a secretory protein, since the m-rbFib H protein contains a signal peptide on the N-terminus as described above, the rbFib H gene also needs to contain a signal DNA encoding a signal peptide on the 5'-end of the rbFib H gene.
[0055] The rbFib H gene in the present specification is not limited in its nucleotide sequence as long as it encodes the rbFib H protein described in aspect 1. Specific examples of the rbFib H gene nucleotide sequence include the nucleotide sequence shown in SEQ ID NO: 14 of the bw592 gene constructed in the Examples described below, and the nucleotide sequence shown in SEQ ID NO: 22 of the bw753 gene.
[0056] 2-2-2. Construction of the modified recombinant bagworm fibroin H chain (m-rbFib H) gene The m-rbFib H gene of this embodiment is a gene encoding the m-rbFib H protein. The nucleotide sequence of the m-rbFib H gene in this specification is not limited as long as it encodes the m-rbFib H protein of the first embodiment. Specific examples of the nucleotide sequence of the m-rbFib H gene include the nucleotide sequence shown in SEQ ID NO: 16 of the bw592ΔN gene, the nucleotide sequence shown in SEQ ID NO: 18 of the bw592ΔC gene, the nucleotide sequence shown in SEQ ID NO: 24 of the bw753ΔN gene, and the nucleotide sequence shown in SEQ ID NO: 26 of the bw753ΔC gene, all of which are constructed in the Examples described below.
[0057] 3. Modified bagworm Fib H chain gene expression vector (m-rbFib H gene expression vector) 3-1. Overview A third aspect of the present invention is an m-rbFib H gene expression vector. The expression vector of the present invention contains the m-rbFib H gene according to the second aspect in a state capable of being expressed in a host cell such as E. coli. By introducing the expression vector of the present invention into a host, the transformant can produce 15 times or more m-rbFib H protein compared to transformation with an rbFib H gene expression vector.
[0058] 3-2.Configuration 3-2-1. Components of the modified bagworm Fib H gene expression vector The m-rbFib H gene expression vector of the present invention is configured to be capable of expressing the m-rbFib H gene in a host cell. The m-rbFib H gene expression vector of this embodiment contains a core vector, an m-rbFib H gene, and a promoter as essential components. In addition, it may contain a terminator, an enhancer, a multicloning site, a selection marker, a polyadenylation signal, a ribosome binding site, a replication origin, and the like as optional components. Each component of the m-rbFib H gene expression vector of this embodiment will be specifically described below.
[0059] (1) Core Vector The core vector is a vector that constitutes the backbone of the m-rbFib H gene expression vector of this embodiment. Various vectors can be used as the core vector. For example, an autonomously replicable vector such as a plasmid or bacmid, a viral vector, or a vector capable of homologous recombination into a chromosome can be mentioned. Usually, a plasmid is sufficient. A vector capable of replicating in the cells of a host organism into which the core vector is introduced is generally selected. The core vector may also be a shuttle vector capable of replicating between other bacteria such as E. coli and arthropods. Furthermore, protein expression vectors in which a promoter, terminator, multicloning site, selection marker, etc., described later, have already been inserted into the core vector, such as the pET system, are commercially available from various life science manufacturers, and these can also be used for the m-rbFib H gene expression vector.
[0060] (2) m-rbFib H gene The m-rbFib H gene contained in the m-rbFib H gene expression vector of the present invention is the m-rbFib H gene described in the second embodiment, and therefore, a detailed description thereof will be omitted here. The m-rbFib H gene is placed under the control of the following promoter in the m-rbFib H gene expression vector.
[0061] (3) Promoter The promoter contained in the m-rbFib H gene expression vector is an essential component that controls the expression of the m-rbFib H gene in the m-rbFib H gene expression vector of the present invention. The promoter is not particularly limited as long as it has a transcription control function in a host cell. Any promoter known in the art may be used. In general, for example, an overexpression type promoter capable of overexpressing a target gene in a host, a constitutively active type promoter capable of constitutively expressing a target gene, and an expression-inducible type promoter capable of freely controlling the expression are known. Any promoter may be used, and may be appropriately determined in consideration of the use and application of the m-rbFib H gene expression vector of the present invention.
[0062] (4) The Terminator The terminator is composed of a base sequence capable of terminating the transcription of the m-rbFib H gene during expression in the m-rbFib H gene expression vector of the present invention. There are no particular limitations on the sequence as long as it is capable of terminating the transcription of the m-rbFib H gene transcribed by the promoter.
[0063] (5) Enhancer An enhancer is a regulatory element that controls a promoter and is an optional component in the m-rbFib H gene expression vector of the present invention. The enhancer may be located in a position within the m-rbFib H gene expression vector that allows it to control the promoter.
[0064] (6) Multiple cloning site The multi-cloning site is a cluster region containing a large number of restriction enzyme sites for cloning, and is an optional component in the m-rbFib H gene expression vector of the present invention. There is no particular limitation on the base sequence constituting the multi-cloning site or the type and number of the restriction enzyme sites contained therein. There is also no particular limitation on the number and position of the multi-cloning sites in the m-rbFib H gene expression vector, but it is preferable to place the m-rbFib H gene in an expressible state at least within the control region of the promoter in the m-rbFib H gene expression vector.
[0065] (7) Selection marker The selection marker can function as a confirmation marker that indicates that the host carries the m-rbFib H gene expression vector of the present invention. In general, a gene encoding an enzyme, a fluorescent protein, a pigment synthesis protein, a luminescent protein, or the like is used as the selection marker. For example, a drug resistance gene (e.g., a tetracycline resistance gene, an ampicillin resistance gene, a kanamycin resistance gene, a hygromycin resistance gene, a spectinomycin resistance gene, a chloramphenicol resistance gene, or a neomycin resistance gene), a nutrient gene (e.g., a biosynthetic gene for leucine, uracil, adenine, histidine, lysine, or tryptophan), a fluorescent or luminescent reporter gene (e.g., luciferase, β-galactosidase, β-glucuronidase (GUS), or GFP), an enzyme gene (neomycin phosphotransferase II (NPT II), dihydrofolate reductase, etc.), an enzyme gene such as a blasticidin S resistance gene, etc. A single m-rbFib H gene expression vector can contain a plurality of selection markers, which may be the same or different.
[0066] The "selection marker" can function as a marker for confirming that the host has the m-rbFib H gene expression vector of this embodiment in the transformant of the third embodiment or its progeny.
[0067] 3-3. Construction of vector expressing m-rbFib H gene The m-rbFib H gene expression vector can be constructed using gene recombination techniques known in the art. A common method, but not limited to, is to cleave both ends of the obtained m-rbFib H gene with appropriate restriction enzymes, purify it, and insert it into a core vector under the control of a promoter and into a restriction site that can be linked to the restriction site.
[0068] 4. Transformants or their progeny 4-1. Overview The fourth aspect of the present invention is a transformant or a progeny thereof transformed by introduction of an m-rbFib H gene expression vector. The transformant or a progeny thereof of the present invention is characterized in that it contains the m-rbFib H gene expression vector of the third aspect in its cells.
[0069] The transformant of the present invention or its progeny can produce a large amount of m-rbFib H protein having the same or similar physical properties as rbFib H protein, and therefore can be used as a system for mass production of rbFib H protein.
[0070] 4-2.Configuration The transformant of the present invention contains the m-rbFib H gene expression vector of the third aspect in the cells. That is, a host transformed by introducing the m-rbFib H gene expression vector of the third aspect becomes the transformant of this aspect. Therefore, the transformant of this aspect is composed of a host and the m-rbFib H gene expression vector of the third aspect.
[0071] Moreover, the term "progeny" refers to the progeny of the transformant, that is, to individual descendants of the transformant.
[0072] Each of these will be explained in detail below. (1) Host The host constituting the transformant of the present invention is not particularly limited as long as it is a microorganism or cell capable of expressing the m-rbFib H gene contained in the m-rbFib H gene expression vector. If the host is a microorganism, examples thereof include prokaryotic organisms such as Escherichia coli and Bacillus subtilis, and fungi such as Saccharomyces cerevisiae and Schizosaccharomyces pombe. If the host is a eukaryotic cell, examples thereof include insect cells (e.g., Sf9, Sf21, SF + Examples of cultured cells include those described above.
[0073] (2) m-rbFib H gene expression vector The m-rbFib H gene expression vector included in the transformant of the present invention or its progeny is the m-rbFib H gene expression vector described in aspect 3. The m-rbFib H gene expression vector may be integrated into the host genome.
[0074] (3)Progeny As used herein, the term "progeny" refers to descendant individuals. Descendant individuals include both asexually reproduced individuals generated by division or the like, and sexually reproduced individuals generated by sexual reproduction.
[0075] In this embodiment, the term "progeny of the transformant" refers to a descendant of the transformant that retains the m-rbFib H gene expression vector of the third embodiment in its cells. The number of generations of the progeny is not limited as long as the progeny retains the m-rbFib H gene expression vector of the third embodiment.
[0076] 4-3. Method for producing transformants The transformant of the present invention is produced by introducing an m-rbFib H gene expression vector into a host. The m-rbFib H gene expression vector may be introduced by a known method according to the host. Examples of methods for introducing the vector into bacteria or yeast include the heat shock method, calcium ion method, electroporation method, spheroplast method, and lithium acetate method. All of these techniques are known in the art and described in various documents. For example, the method described in Green & Sambrook, Molecular Cloning: A Laboratory Manual, 4th Ed., (2012), Cold Spring Harbor Laboratory Press may be referred to. In addition, examples of methods for introducing the vector into cells include the lipofectin method (PNAS, 1989, 86: 6077; PNAS, 1987, 84: 7413), electroporation method, calcium phosphate method (Virology, 1973, 52: 456-467), liposome method, and DEAE-Dextran method.
[0077] 5. Method for producing modified recombinant bagworm fibroin H chain protein (m-rbFib H protein) 5-1. Overview The fifth aspect of the present invention is a method for producing m-rbFib H protein. The m-rbFib H protein obtained by this production method is a target protein in the bagworm silk industry. According to the production method of this aspect, m-rbFib H protein can be mass-produced in transformant cells such as E. coli.
[0078] 5-2. Method The production method of this embodiment includes a culture step and a preparation step as essential steps. Each step will be described below. (1)Culture process The "culturing step" refers to a step of culturing the transformant of the fourth aspect or its progeny under predetermined conditions. The predetermined conditions refer to optimal culture conditions for the host of the transformant. For example, if the host is Escherichia coli, the conditions refer to culturing the transformant for 6 to 12 hours at 37°C while aerating the transformant after inoculation into a known medium such as LB medium. The culture conditions may be determined by appropriately applying an optimal culture method according to the type of host using a known method.
[0079] This process may include an expression induction step. The "expression induction step" is a step of inducing the expression of the m-rbFib H gene inserted into the m-rbFib H gene expression vector. The necessity of this step is determined depending on the type of promoter that controls the expression of the m-rbFib H gene in the m-rbFib H gene expression vector. For example, when the promoter is an expression induction type promoter, this step is necessary. On the other hand, when the promoter is a constitutively active promoter, this step is not necessary because the m-rbFib H gene is constantly expressed in the transformant. The expression induction method may be performed according to the properties of the expression induction type promoter. For example, when the m-rbFib H gene expression vector is placed under a pET system using T7 RNA polymerase and a T7 promoter, the lac promoter in the pET system is activated by adding an expression inducer such as IPTG to the medium, and the transcription of the inserted gene placed under its control (here, the m-rbFib H gene) is strongly promoted. All of these are known protein expression methods, and reference may be made to the above-mentioned Green & Sambrook, 2012.
[0080] (2) Preparation process The "preparation step" is a preparation step for preparing m-rbFib H protein from the culture medium and / or the transformant after the culture step. When the m-rbFib H gene contained in the m-rbFib H gene vector contains a signal DNA, the expressed m-rbFib H protein is secreted outside the cells, and therefore most of the biosynthesized m-rbFib H protein is present in the culture medium. On the other hand, when the m-rbFib H gene does not contain a signal DNA, the biosynthesized m-rbFib H protein is accumulated in the host cells. This step is a step for recovering the m-rbFib H protein present in the culture medium or in the transformant cells.
[0081] The target m-rbFib H protein may be collected from the culture medium by a protein purification method known in the art. For example, a purified m-rbFib H protein may be obtained by appropriately selecting or combining methods such as ammonium sulfate precipitation, ion exchange chromatography, affinity chromatography, and gel chromatography. In addition, the m-rbFib H protein accumulated in the host cells may be extracted by disrupting the host cells by physical and / or chemical treatment, and then purifying the cell lysate supernatant by the same protein purification method as above. All of these protein purification methods are known, and can be found in Methods in Enzymology, vol. 463, Guide to Protein Purification 2nd ed., (2009). EXAMPLES
[0082] Example 1: Construction of recombinant bagworm fibroin H gene (the purpose) Using the base information of the bagworm Fib H gene identified in JP 2018-074403, a new bagworm Fib H gene will be cloned and then the rbFib H gene will be constructed. (method) Silk glands were excised from final instar larvae of the giant silk moth, and total RNA was extracted using the RNeasy Mini Kit (QIAGEN). A cDNA library of the giant silk moth was then constructed using the total RNA as a template and random hexamers as primers with SuperScript III First-Strand Synthesis SuperMix (Invitrogen).
[0083] (1) Cloning of the 5'-terminal region of the bFib H gene For cDNA cloning of the 5'-terminal side of the bFib H gene, a PCR primer pair consisting of SEQ ID NOs: 30 and 31 was designed. PCR was performed using the primer pair and PrimeSTAR GXL DNA Polymerase (Takara Bio) according to the standard protocol described in the instruction manual (98°C, 2 minutes → [98°C, 10 seconds → 68°C, 2 minutes] × 30 cycles → 68°C, 2 minutes → 4°C). After separating the amplified product by agarose gel electrophoresis, a band of about 1,600 bp was excised, and the DNA fragment was extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). The obtained DNA fragment was inserted into the HincII site of the pUC118 vector using Mighty Cloning Reagent Set (Blunt End) (Takara Bio) to prepare a plasmid vector "pUC118-bw-N" containing the 5'-terminal region of the bFib H gene. The nucleotide sequence of the inserted fragment was then determined. As a result, the nucleotide sequence information of the 5'-terminal region of the bFib H gene consisting of 1,608 bp as shown in SEQ ID NO: 32 was clarified. This 5'-terminal region encodes, in order from the N-terminus of the bFib H protein, a signal sequence, an N-terminal region, and a part of the central repeat region.
[0084] Next, in order to remove the coding region of the signal sequence, a PCR primer pair consisting of the base sequences shown in SEQ ID NOs: 33 and 34 with the addition of a restriction enzyme cleavage sequence was designed using pUC118-bw-N as a template. PCR was performed using the primer pair and PrimeSTAR GXL DNA Polymerase (Takara Bio). As a result of separating the amplified products by agarose gel electrophoresis, a short band of about 600 pb and a long band of about 1 kb were obtained. After cutting out each band, the DNA fragments were extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). Then, the DNA fragments of about 600 pb and about 1 kb were inserted into the HincII site of the pUC118 vector using DNA Ligation Kit, Mighty Mix (Takara Bio). The obtained plasmid vectors were named "pUC118-bw-NS" and "pUC118-bw-NL", respectively. The nucleotide sequence of the inserted fragment in each plasmid vector was confirmed, revealing the 585 bp nucleotide sequence information shown in SEQ ID NO:35 and the 1,068 bp nucleotide sequence information shown in SEQ ID NO:36.
[0085] (2) Cloning of the 3'-terminal region of the bFib H gene For cDNA cloning of the 3'-terminal side of the bFib H gene, a PCR primer pair consisting of SEQ ID NOs: 37 and 38 was designed. PCR was performed using the primer pair and PrimeSTAR GXL DNA Polymerase (Takara Bio) according to the standard protocol described in the instruction manual (98°C, 2 minutes → [98°C, 10 seconds → 68°C, 2 minutes] × 30 cycles → 68°C, 2 minutes → 4°C). After separating the amplified product by agarose gel electrophoresis, a band of about 1,200 bp was excised, and the DNA fragment was extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). The obtained DNA fragment was inserted into the HincII site of the pUC118 vector using Mighty Cloning Reagent Set (Blunt End) (Takara Bio) to prepare a plasmid vector "pUC118-bw-C" containing the 3'-terminal region of the bFib H gene. The nucleotide sequence of the inserted fragment was then determined. As a result, the nucleotide sequence information of the 3'-terminal region of the bFib H gene consisting of 1,179 bp as shown in SEQ ID NO: 39 was clarified. This 3'-terminal region encodes, in order from the N-terminus side of the bFib H protein, a part of the central repeat region and the C-terminal region.
[0086] (3) Construction of rbFib H gene (i) To construct the rbFib H gene, pUC118-bw-NS prepared in (1) was treated with NheI / HindIII. After the cleavage products were separated by agarose gel electrophoresis, the 585 bp band derived from pUC118-bw-NS was cut out from the gel, and the DNA fragment was extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). The obtained DNA fragment derived from pUC118-bw-NS was designated as "bw-NS (N / H)". Next, pUC118-bw-C prepared in (2) was cleaved with NheI / HindIII. The obtained open circular plasmid vector was designated as "pUC118-bw-C (N / H)", and this pUC118-bw-C (N / H) was ligated with the bw-NS (N / H) to obtain the "pUC118-bw592" cloning vector.
[0087] (ii) The pUC118-bw592 was treated with EcoRI / NheI to obtain a cloning vector "pUC118-bw592-C" containing only the 3'-terminal gene. The pUC118-bw-NL prepared in (1) was cleaved with the same restriction enzymes. The 1068 bp band was excised from the gel, and the DNA fragment was extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). The resulting DNA fragment derived from pUC118-bw-NL and corresponding to the 5'-terminal region of the bFib H gene was named "bw-NL (E / N)". pUC118-bw592-C and bw-NL (E / N) were ligated to obtain the "pUC118-bw753" cloning vector. pUC118-bw592 and pUC118-bw753 are rbFib H genes with different numbers of bases that code for rbFib H proteins consisting of 592 amino acids and 753 amino acids derived from Bombyx mori, respectively. In this specification, the genes are referred to as "bw592 gene" (SEQ ID NO: 14) and "bw753 gene" (SEQ ID NO: 22). The rbFib H protein encoded by the bw592 gene is referred to as "bw592 protein" and its amino acid sequence is shown in SEQ ID NO: 15. As shown in FIG. 1, the bw592 protein consists of the N-terminal region, three central repeat regions, and the C-terminal region of the bFib H protein. On the other hand, the rbFib H protein encoded by the bw753 gene is referred to as "bw753 protein" and its amino acid sequence is shown in SEQ ID NO: 23. As shown in FIG. 1, the bw753 protein consists of the N-terminal region, four central repeat regions, and the C-terminal region of the bFib H protein.
[0088] <Example 2: Construction of recombinant bagworm fibroin H chain gene expression vector and preparation of E. coli transformant> (the purpose) A gene expression vector is constructed that contains in an expressible state the rbFib H gene cloned in Example 1. The gene expression vector is then introduced into a host, E. coli, to prepare an E. coli transformant capable of expressing the rbFib H gene.
[0089] (method) (1) Construction of rbFib H gene expression vector In order to express the bw592 gene and the bw753 gene prepared in Example 1(3) in E. coli, each of the cloning vectors pUC118-bw592 and pUC118-bw753 was treated with NcoI / XhoI to obtain DNA fragments of bw592 and bw753. Next, the expression vector pET-22b(+) (Novagen) was similarly treated with NcoI / XhoI, and then bw592 and bw753 were inserted into the same site. The obtained expression vectors were named "pET-22b-bw592" and "pET-22b-bw753", respectively. (2) Preparation of E. coli transformants expressing rbFib H gene After purifying each of the rbFib H gene expression vectors constructed in (1), they were introduced into E. coli BL21(DE3), BLR(DE3), and Rosetta2(DE3) cells (all from Novagen) using standard methods to prepare E. coli transformants capable of expressing the rbFib H gene (rbFib H-expressing E. coli strains).
[0090] <Example 3: Construction of modified recombinant bagworm fibroin H chain gene expression vector and preparation of E. coli transformant> (the purpose) A modified rbFib H gene (m-rbFib H gene) is constructed by adding various mutations to the rbFib H gene cloned in Example 1. The gene expression vector is then introduced into the host Escherichia coli to prepare an Escherichia coli transformant capable of expressing the m-rbFib H gene. (method) (1) Construction of m-rbFib HΔC gene expression vector For each of the rbFib H genes, bw592 and bw753, we used PCR to create ΔC-terminal deletion mutants of the rbFib H genes (referred to as "m-rbFib HΔC genes") in which the nucleotide sequence encoding the C-terminal region was deleted while maintaining the central repeat region, which is highly related to the physical properties of silk.
[0091] Using pET-22b-bw592 and pET-22b-bw753 constructed in Example 2 as templates, PCR was performed using a primer pair (SEQ ID NOs: 40 and 41) to which an NcoI / XhoI cleavage site was added at the 5' end. After separating the amplified products by agarose gel electrophoresis, bands of predicted sizes were excised, and DNA fragments were extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). The resulting DNA fragments were treated with NcoI / XhoI to obtain NcoI / XhoI-DNA fragments of "bw592ΔC" (SEQ ID NO: 18) and "bw753ΔC" (SEQ ID NO: 26), which are ΔC variants of bw592 and bw753. These DNA fragments were inserted into the NcoI / XhoI site of pET-22b(+) (Novagen) treated with NcoI / XhoI. The obtained expression vectors were named "pET-22b-bw592ΔC" and "pET-22b-bw753ΔC", respectively. The rbFib H protein encoded by the bw592ΔC gene is referred to as "bw592ΔC protein" and its amino acid sequence is shown in SEQ ID NO: 19. The rbFib H protein encoded by the bw753ΔC gene is referred to as "bw753ΔC protein" and its amino acid sequence is shown in SEQ ID NO: 27.
[0092] (2) Construction of m-rbFib HΔN gene expression vector For each of the rbFib H genes, bw592 and bw753, we used PCR to create ΔN-terminal deletion mutants of the rbFib H genes (referred to as "m-rbFib HΔN genes") in which the nucleotide sequence encoding the N-terminal region was deleted while maintaining the central repeat region, which is highly related to the physical properties of silk.
[0093] Using pET-22b-bw592 and pET-22b-bw753 constructed in Example 2 as templates, PCR was performed using a primer pair (SEQ ID NOs: 42 and 43) to which an NcoI / XhoI cleavage site was added at the 5' end. After separating the amplified products by agarose gel electrophoresis, bands of predicted sizes were excised, and DNA fragments were extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). The resulting DNA fragments were treated with NcoI / XhoI to obtain NcoI / XhoI-DNA fragments of "bw592ΔN" (SEQ ID NO: 16) and "bw753ΔN" (SEQ ID NO: 24), which are ΔN variants of bw592 and bw753. These DNA fragments were inserted into the NcoI / XhoI site of pET-22b(+) (Novagen) treated with NcoI / XhoI. The obtained expression vectors were named "pET-22b-bw592ΔN" and "pET-22b-bw753ΔN", respectively. The rbFib H protein encoded by the bw592ΔN gene is referred to as "bw592ΔN protein" and its amino acid sequence is shown in SEQ ID NO: 17. The rbFib H protein encoded by the bw753ΔN gene is referred to as "bw753ΔN protein" and its amino acid sequence is shown in SEQ ID NO: 25.
[0094] (3) Construction of m-rbFib HΔN / C gene expression vector For each of the rbFib H genes, bw592 and bw753, we used PCR to create double-deleted mutants of the rbFib H genes (referred to as "m-rbFib HΔN / C genes") in which the base sequences encoding the N- and C-terminal regions were deleted while maintaining only the central repeat region, which is highly related to the physical properties of silk.
[0095] PCR was performed using the primer pair (SEQ ID NO: 42 and 41) and pET-22b-bw592 and pET-22b-bw753 constructed in Example 2 as templates. After the amplified products were separated by agarose gel electrophoresis, bands of the predicted sizes were excised, and DNA fragments were extracted and purified using Wizard (registered trademark) SV Gel and PCR Clean-Up System (Promega). The resulting DNA fragments were treated with NcoI / XhoI to obtain NcoI / XhoI-DNA fragments of "bw592ΔN / C" (SEQ ID NO: 20) and "bw753ΔN / C" (SEQ ID NO: 28), which are ΔN / C variants of bw592 and bw753. These DNA fragments were inserted into the NcoI / XhoI site of pET-22b(+) (Novagen) treated with NcoI / XhoI. The obtained expression vectors were named "pET-22b-bw592ΔN / C" and "pET-22b-bw753ΔN / C", respectively. The rbFib H protein encoded by the bw592ΔN / C gene is referred to as "bw592ΔN / C protein" and its amino acid sequence is shown in SEQ ID NO: 21. The rbFib H protein encoded by the bw753ΔN / C gene is referred to as "bw753ΔN / C protein" and its amino acid sequence is shown in SEQ ID NO: 29.
[0096] (4) Preparation of E. coli transformants expressing rbFib H gene After purifying each of the m-rbFib H gene expression vectors constructed in (1) to (3), they were introduced into the cells of E. coli BL21 (DE3) strain (Novagen) by a conventional method to prepare E. coli transformants capable of expressing the m-rbFib H gene (m-rbFib H-expressing E. coli strains). The transformants into which the bw592 gene, the bw592ΔN gene, the bw592ΔC gene, the bw592ΔN / C gene, the bw753 gene, the bw753ΔN gene, the bw753ΔC gene, and the bw753ΔN / C gene were introduced are referred to as the bw592 strain, the bw592ΔN strain, the bw592ΔC strain, the bw592ΔN / C strain, the bw753 strain, the bw753ΔN strain, the bw753ΔC strain, and the bw753ΔN / C strain, respectively.
[0097] <Example 4: Verification of the expression level of bFib H protein using E. coli transformants> (the purpose) The rbFib H protein or m-rbFib H protein is expressed in the various rbFib H-expressing E. coli strains or m-rbFib H-expressing E. coli strains prepared in Examples 2 and 3, and the expression levels are examined. (method) Each of the various rbFib H-expressing E. coli strains (bw592 strain, bw753 strain) or m-rbFib H-expressing E. coli strains (bw592ΔN strain, bw592ΔC strain, bw592ΔN / C strain, bw753ΔN strain, bw753ΔC strain, and bw753ΔN / C strain) prepared in Examples 2 and 3 was inoculated into LB medium (Thermo Fisher Scientific), cultured at 37°C, and the turbidity was measured using a WPA CO8000 Cell Dense Meter (Biowave). When the turbidity reached 0.4 to 0.6, IPTG was added to a final concentration of 1 mM, and the mixture was further cultured at 25°C for 4 hours. After the culture, the cells were collected by centrifugation, suspended in a solubilization buffer (BugBuster reagent (Merck) supplemented with Lysonase (Merck) and PMSF (Sigma-Aldrich)), and left at room temperature for 10 minutes, then centrifuged at 20,000×G for 15 minutes at 4° C. to collect the supernatant. The supernatant was electrophoresed on a 10% or 12% SDS-polyacrylamide gel, and the separated peptides were transferred to a PVDF membrane using a TransBlot Turbo Transfer System (Bio-Rad) at 1.3 A, 25 V, and 7 minutes.
[0098] In the E. coli strains prepared in Examples 2 and 3, the rbFib H protein or m-rbFib H protein expressed from each expression vector has a His6 tag at the C-terminus. Therefore, the PVDF membrane after the transfer treatment was blocked with skim milk, and then reacted with a 5,000-fold diluted HRP-labeled anti-His antibody (Anti-His-tag mAb-HRP-DirecT; MBL) according to the attached protocol. Then, a luminescence reaction based on HRP activity was performed using the luminescence substrate Western Lightning Plus-ECL (Perkin Elmer).
[0099] (result) The results are shown in Figure 2. As can be seen from this figure, the bw592 strain expressing unmodified rbFib H protein expressed the desired rbFib H protein, but in small amounts (lane 1). When rbFib H protein containing the basic components of Fib H protein is expressed in E. coli, some kind of control mechanism appears to suppress the expression. This unknown control mechanism is extremely inconvenient for the purpose of the present invention, which is to mass-produce rbFib H protein in a microbial expression system or the like.
[0100] On the other hand, in the bw592ΔN strain expressing m-rbFib H-bw592ΔN protein in which the N-terminal region was deleted from the Fib H protein, the expression level of the m-rbFib H-bw592ΔN protein was significantly increased, and no degradation of the m-rbFib H-bw592ΔN protein was observed (lane 3). Therefore, it was revealed that the use of a gene encoding the m-rbFib H-bw592ΔN protein in which all or part of the N-terminal region was deleted can be used to mass-produce rbFib H protein having protease resistance.
[0101] In contrast, in the bw592ΔC strain expressing m-rbFib H-bw592ΔC protein in which the C-terminal region of Fib H protein has been removed, many degradation products of m-rbFib H-bw592ΔC protein were confirmed, unlike the bw592ΔN strain (lane 2). This result suggests that the C-terminal region contributes to the resistance of rbFib H protein to protease degradation. However, in the bw592ΔC strain, expression of an overwhelming amount of m-rbFib H-bw592ΔC protein exceeding the amount of degradation was confirmed. Therefore, it was revealed that in order to mass-produce rbFib H protein, it is sufficient to use a gene encoding m-rbFib H-bw592ΔC protein in which all or part of the C-terminal region has been removed, and extract non-degradation products after expression.
[0102] Furthermore, the expression level of m-rbFib H protein was also examined in the bw592ΔN / C strain expressing m-rbFib H-bw592ΔN / C protein, which is essentially composed of only the central region of Fib H protein, excluding both the N-terminal and C-terminal regions. As a result, the expression level was higher than that of the bw592 strain expressing rbFib H protein, but the amount of degradation products also increased at the same time. On the other hand, the dramatic increase in the expression level of m-rbFib H-bw592ΔN / C protein was not observed as much as in the bw592ΔC strain (lane 4).
[0103] The above tendency was also observed in the bw753 strain, the bw753ΔN strain, the bw753ΔC strain, and the bw753ΔN / C strain (not shown).
[0104] Therefore, the luminescence intensity in the bw592 and bw592ΔC strains, and the bw753 and bw753ΔC strains was quantified using a luminometer image analyzer Amersham Imager 600 (GE Healthcare), and the expression levels of rbFib H protein and m-rbFib H protein were calculated using the dedicated software (v.1.2) that came with the instrument. The results are shown in Table 1.
[0105] [Table 1]
[0106] Table 1 shows the relative expression levels of the bw592ΔC and bw753ΔC strains, respectively, when the expression levels of the bw592 and bw753 strains expressed in E. coli are set to 1. The expression level of the bw592ΔC strain was approximately 20-fold higher than that of the bw592 strain, and that of the bw753ΔC strain was approximately 16-fold higher than that of the bw753 strain. The only difference between the bw592ΔC and bw753ΔC strains is the number of CRUs.
[0107] From the above results, it was shown that when rbFib H protein is expressed in microbial cells such as E. coli, the expression level of m-rbFib H protein can be increased by using a gene encoding m-rbFib H protein in which either the N-terminal region or the C-terminal region has been entirely or partially deleted, regardless of the number of CRUs. On the other hand, it was also revealed that when both termini were deleted, the expression level was higher than that of rbFib H protein, but the degradation level also increased, resulting in a relative decrease in the expression level. All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety.
Claims
1. A modified recombinant bagworm fibroin H chain protein with enhanced expression, which is obtained by modifying a recombinant bagworm fibroin H chain protein that includes, in order from the N-terminus, an N-terminal region, a central region, and a C-terminal region, The expression-enhanced modified recombinant bagworm fibroin H chain protein is The entire N-terminal region or 20 or more amino acids that eliminate the expression inhibitory function of the recombinant bagworm fibroin H chain protein, or The entire C-terminal region or 5 or more amino acids that cause the expression inhibitory function of the recombinant bagworm fibroin H chain protein to be lost are deleted, The N-terminal region The amino acid sequence shown in SEQ ID NO: 1, or An amino acid sequence having 90% or more amino acid identity with the amino acid sequence shown in SEQ ID NO: 1 and having the function of inhibiting the expression of the recombinant bagworm fibroin H chain protein. It consists of: The central region is a region that exhibits the physical properties of bagworm fibroin H chain protein, and is composed of three or more central repeat units consisting of the same and / or different amino acid sequences linked together, The C-terminal region The amino acid sequence shown in SEQ ID NO:2, or An amino acid sequence having 90% or more amino acid identity with the amino acid sequence shown in SEQ ID NO: 2 and having the function of inhibiting the expression of the recombinant bagworm fibroin H chain protein. where The central repeating unit contains 30 or more units of two amino acid units consisting of glycine and alanine, and an alanine cluster containing 15 to 25 alanines on the N-terminal side, and is composed of 120 to 170 amino acids in total. The protein.
2. The expression-enhanced modified recombinant bagworm fibroin H chain protein described in claim 1, wherein the alanine cluster consists of the amino acid sequence shown in SEQ ID NO: 3 or 4.
3. The expression-enhanced modified recombinant bagworm fibroin H chain protein of claim 2, wherein the central repeat unit is selected from the amino acid sequences shown in SEQ ID NOs: 5 to 13.
4. An expression-enhanced modified recombinant bagworm fibroin H chain gene encoding an expression-enhanced modified recombinant bagworm fibroin H chain protein according to any one of claims 1 to 3.
5. An expression-enhancing modified recombinant bagworm fibroin H chain gene as described in claim 4, consisting of any of the base sequences shown in SEQ ID NO: 16, 18, 24, or 26.
6. An expression-enhancing modified recombinant bagworm fibroin H chain gene expression vector comprising the expression-enhancing modified recombinant bagworm fibroin H chain gene according to claim 4 or 5 in a state capable of being expressed in a host cell.
7. A transformant comprising a host containing the expression-enhancing modified recombinant bagworm fibroin H chain gene expression vector described in claim 6, or a descendant thereof containing said expression vector.
8. The transformant or its progeny according to claim 7 , wherein the host is a microorganism or a cultured insect cell.
9. A method for producing an expression-enhanced modified recombinant bagworm fibroin H chain protein, comprising the steps of: culturing the transformant or its progeny according to claim 7 or 8 under predetermined conditions; and A preparation step of preparing an expression-enhanced modified recombinant bagworm fibroin H chain protein from the culture solution and / or transformant after the culture step. The manufacturing method comprising the steps of:
Citation Information
Patent Citations
Recombinant spider silk protein
JP2008506409A
Remote controller
JP2018074403A
Method for producing long yarn of bagworm, and apparatus for producing the same
JP2018197415A
Fiber forming device
JP2019013207A
Fibroin-like protein production method
WO2015178466A1
